Mouse lung development and NOX1 induction during hyperoxia are developmentally regulated and mitochondrial ROS...

Area of Science:

• Neonatal physiology
• Pulmonary medicine
• Cardiovascular development

Background:

• Neonatal hyperoxia (high oxygen exposure) impairs lung and pulmonary vascular development, resembling bronchopulmonary dysplasia (BPD).
• Antioxidant enzyme capacity matures postnatally, and mitochondrial oxidative stress is developmentally regulated in hyperoxia.
• The impact of hyperoxia on neonatal development may be age-dependent and linked to mitochondrial reactive oxygen species (ROS).

Purpose of the Study:

• To investigate the developmental regulation of hyperoxia's effects on lung and cardiovascular development.
• To determine if mitochondrial ROS mediate the consequences of neonatal hyperoxia.
• To explore the potential of targeted antioxidant therapy for preventing hyperoxic lung injury.

Main Methods:

• Neonatal mice were exposed to 75% oxygen for 72 hours at either postnatal day 0 (early) or day 4 (late).
• Mice received either a mitochondria-specific antioxidant (mitoTEMPO) or placebo during early hyperoxia.
• Lung structure, pulmonary artery muscularization, right ventricular hypertrophy (RVH), and NOX1 expression were assessed.

Main Results:

• Early postnatal hyperoxia, but not late, caused impaired alveolarization, increased pulmonary artery muscularization, and RVH.
• MitoTEMPO treatment during early hyperoxia prevented alveolar and RVH deficits.
• Early hyperoxia induced NOX1 expression in a mitochondrial ROS-dependent manner, which was not observed with late exposure.

Conclusions:

• The detrimental effects of neonatal hyperoxia on lung and cardiovascular development are developmentally regulated and diminish with age.
• Mitochondrial ROS play a critical role in the pathophysiology of neonatal hyperoxic lung injury.
• Targeted antioxidant therapy, particularly for mitochondrial ROS, shows promise for preventing or treating BPD.